Pathologic Stage I Gastroesophageal Junction Adenocarcinoma AJCC v8
1 clinical trials · Condition
◉ Watch Pathologic Stage I Gastroesophageal Junction Adenocarcinoma AJCC v8
| Record | Firm | Date |
|---|---|---|
| Chemoradiation and Pembrolizumab Followed by Pembrolizumab and Lenvatinib Before Surgery for the Treatment of Non-metastatic Esophageal or Esophageal/Gastroesophageal Junction Cancer (NCT04929392) | City of Hope Medical Center | 2022-01-25 |
Track Pathologic Stage I Gastroesophageal Junction Adenocarcinoma AJCC v8 automatically
Every clearance here is in the API, with alerts when new ones post.